People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other Health Care, Biotechnology, Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Fractyl Laboratories Inc. | — | Other Health Care | Series C | $290.1M | $309.5M | 2014 |
| Glympse Bio, Inc. | — | Biotechnology | Series C | $114.0M | $324.7M | 2020 |
| Daktari Diagnostics, Inc. | — | Biotechnology | Series B | $76.3M | $893.0M | 2009 |
| PathAI, Inc. | — | Other Technology | Series C | $74.9M | $1.9B | 2019 |
| Mercy BioAnalytics, Inc. | — | Biotechnology | Series B | $27.3M | $919.0M | 2020 |
| Mirvie, Inc. | — | Other | Series B | $23.7M | $113.3M | 2025 |
| Droplet Biosciences, Inc. | — | Biotechnology | Series A | $13.0M | $53.1M | 2021 |
Stanley Lapidus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stanley Lapidus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amy Schulman | 2 | 11 |
| Robert Langer | 1 | 36 |
| Samir Kaul | 1 | 32 |
| Hemant Taneja | 1 | 21 |
| Ajay Royan | 1 | 13 |
| Paul Meister | 1 | 12 |
| David Rubin | 1 | 11 |
| Ann DeWitt | 1 | 10 |
| George Zachary | 1 | 9 |
| Alexandra Cantley | 1 | 8 |
| Theresia Gouw | 1 | 8 |
| Brian H. Dovey | 1 | 7 |
| Sonja Hoel Perkins | 1 | 7 |
| Brian Dovey | 1 | 7 |
| Aaron Sandoski | 1 | 7 |
| Diane Marcou | 1 | 5 |
| Roger Kitterman | 1 | 5 |
| John McDonough | 1 | 5 |
| MIN CUI | 1 | 5 |
| Rachel Sha | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.